Call for tender - Development Effectiveness Evaluation
BIO’s management contract provides that, each year, a sample of BIO’s interventions must be subject to an in-depth assessment of their development effects.
The ultimate goals of this assessment are:
- improving existing policies and practices and
- establishing new ones through lessons learning and evidence-base.
BIO has just published a call for tender for the next 3 Development Effectiveness Evaluations (period 2022- 2024), including a detailed Terms of Reference for the next evaluation that will focus on “BIO’s contribution to SDG10 – Reduced inequality and inclusive businesses”.
Belgian impact investor Incofin IM raises 45 million euros in a first investment round for its new impact fund focused on rural development in India.
During a launch ceremony at Résidence de Belgique in Abidjan, last Thursday, October 14, the Belgian Investment Company for Developing Countries (BIO) celebrated the opening of its first African office in Abidjan.
On the 27th of September 2021, Oxfam Belgium published the report ″Fuelling human rights violations″ addressing the problematic consequences of a bioethanol project co-financed by BIO. Oxfam's testimonies on the excesses concerning environment and health are mostly dated after 2015, two years after Maple Etanol prematurely reimbursed BIO and left our portfolio. Since then BIO no longer had access to the monitoring reports either.